SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve Unaudited financial ....
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Haleos Labs Ltd (formerly SMS Lifesciences India) has informed the stock exchanges that its 95th Board Meeting is scheduled for November 10, 2025. The main agenda is to consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2025 (Q2 FY26 / H1 FY26). The company has also closed its trading window for designated persons and their immediate relatives until November 12, 2025, in line with insider trading rules. The company is also in the process of adopting its new name 'Haleos Labs Limited' with the regulators. No financial numbers or forecasts are disclosed in this intimation.
This is a routine regulatory filing ahead of the upcoming Q2 FY26 results announcement. Shareholders should watch the November 10 meeting for actual revenue, profit, and margin numbers, which will be the first material data point from the company under its new name. Short-term stock movement may be muted until results are out.